Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organoheterocyclic compounds
(total 322 related compounds in database, current show from 161 to 170)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
methyl (1S,12S)-16-[(4,6-dichloro-2H-chromen-3-yl)methyl]-13-oxo-3,16-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraene-14-carboxylate Depiction based on curated SMILES Cl O Cl N H O O H CH 3 H O N Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2008. Angew Chem Int Ed Engl
methyl (1S,12S)-16-[(4-chloro-6-fluoro-2H-chromen-3-yl)methyl]-13-oxo-3,16-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraene-14-carboxylate Depiction based on curated SMILES F O Cl N H O O H CH 3 H O N Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2008. Angew Chem Int Ed Engl
methyl (1S,12S)-16-[(5-chloro-1H-indol-3-yl)methyl]-13-oxo-3,16-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraene-14-carboxylate Depiction based on curated SMILES Cl N H N H O O H CH 3 H O N Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2008. Angew Chem Int Ed Engl
methyl (1S,12S)-16-[(5-methylfuran-2-yl)methyl]-13-oxo-3,16-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraene-14-carboxylate Depiction based on curated SMILES H CH 3 O O NH CH 3 O H N O Mycobacterium Exoenzyme Preclinical (in vitro) Nören-Müller A, et al. 2008. Angew Chem Int Ed Engl
N-{1-[4-(4-FLUOROPHENYL)PIPERAZIN-1-YL]-1-(THIOPHEN-2-YL)PROPAN-2-YL}-N'-[(PYRIDIN-3-YL)METHYL]ETHANEDIAMIDE Depiction based on curated SMILES HN F HN O O N S N CH 3 N Mycobacterium Exoenzyme Preclinical (in vitro) Chen L, et al. 2010. ACS Med Chem Lett
N-(2,5-dimethylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide Depiction based on curated SMILES O N N CH 3 O N H CH 3 Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
N-(2-methyl-5-nitrophenyl)-2-(4-oxoquinazolin-3(4H)-yl)acetamide Depiction based on curated SMILES O O N N H 3 C N H _ O O + N Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
N-(5-chloro-2-methoxyphenyl)-2-(7-methyl-4-oxo-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-3-yl)acetamide Depiction based on curated SMILES S H 3 C O N CH 3 N O N H Cl O Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
N-(5-chloro-2-methylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide Depiction based on curated SMILES O N N CH 3 O N H Cl Mycobacterium Immune modulation Preclinical (in vitro) Karanja CW, et al. 2021. ACS Infect Dis
N-[(FURAN-2-YL)METHYL]-N'-{1-[4-(4-METHOXYPHENYL)PIPERAZIN-1-YL]-1-(THIOPHEN-2-YL)PROPAN-2-YL}ETHANEDIAMIDE Depiction based on curated SMILES O O H 3 C HN O HN O S N CH 3 N Mycobacterium Exoenzyme Preclinical (in vitro) Chen L, et al. 2010. ACS Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  ...  33



Back to top
2004-2024 NIPB, CAMS&PUMC